開能健康(300272.SZ):擬以1.75億元出售信川投資100%股權
格隆匯11月22日丨開能健康(300272.SZ)公佈,上海信川投資管理有限公司(“信川投資”、“目標公司”或“標的公司”)是公司持有100%股權的全資子公司。為提高資產運營效率,進一步籌集資金,滿足公司整體發展戰略所需,公司於2021年11月20日與麗水原信產業發展有限公司(“麗水原信”或“受讓方”)簽訂《股權轉讓協議》,開能健康擬以人民幣1.75億元的價格將其所持有的信川投資100%股權轉讓給麗水原信。此次轉讓完成後,開能健康不再持有信川投資股權。
此次交易標的資產為信川投資100%股權,標的資產經營所在地為上海市浦東新區川大路508號。信川投資主要資產為其擁有的房屋、土地使用權(權證編號為滬(2017)浦字不動產權第074047號,建築面積30274.29平方米,土地面積25721.10平方米)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.